Clinical Trial: Pramipexole for Binge Eating Disorder
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: An Exploration of the Effects of the Dopamine Agonist Pramipexole on Binge Antecedants, Binge Frequency, and Weight in B
Brief Summary: This study is being conducted to evaluate the effects that the drug pramipexole has on mood, food craving, and other behaviors that may be related to binge eating disorder.
Detailed Summary:
Sponsor: Neuropsychiatric Research Institute, Fargo, North Dakota
Current Primary Outcome: Frequency of binge eating [ Time Frame: Baseline followed by weekly during the seven week protocol ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Body weight [ Time Frame: Baseline followed by weekly during the seven week protocol ]
- Frequency and extent of craving for food using validated instruments [ Time Frame: Baseline followed by weekly during the seven week protocol ]
- Assessment of mood ratings using a validated instrument [ Time Frame: Baseline followed by weekly during the seven week protocol ]
Original Secondary Outcome: Same as current
Information By: Neuropsychiatric Research Institute, Fargo, North Dakota
Dates:
Date Received: April 15, 2010
Date Started: April 2010
Date Completion:
Last Updated: May 3, 2013
Last Verified: May 2013
